Merck & Co., Inc. (BCBA:MRK)

Argentina flag Argentina · Delayed Price · Currency is ARS
32,960
-200 (-0.60%)
Last updated: Jan 20, 2026, 12:45 PM BRT
41.31%
Market Cap389.64T
Revenue (ttm)88.03T
Net Income (ttm)26.09T
Shares Outn/a
EPS (ttm)10,355.40
PE Ratio14.94
Forward PE19.45
Dividend546.54 (1.66%)
Ex-Dividend DateDec 15, 2025
Volume2,494
Average Volume3,180
Open32,720
Previous Close33,160
Day's Range32,560 - 32,960
52-Week Range16,950 - 34,500
Beta0.30
RSI59.13
Earnings DateFeb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements